Tag: focus

Trim IQ UK And Ireland is a powerful weight loss Dietary Supplement management solution that targets fat, Garcinia & Green Tea Probiotic Complex curbs cravings, and supports healthy energy and focus and boost energy naturally.

Matsato Kitchen Knife official launch of the Matsato Knife a high-performance culinary blade crafted for chefs and home cooks across Australia, the United States, Canada, and the UK. Engineered for razor-sharp precision, ergonomic comfort, and long-lasting durability. transform your cooking experience

SINGAPORE, Aug. 02, 2025 (GLOBE NEWSWIRE) -- As Bitcoin continues to surge to new highs and the market enters a phase of high volatility, holding traditional spot positions may not be enough to generate short-term profits. With Bitcoin's price moving rapidly, traders are seeking more effective ways to capitalize on these fluctuations. In response to this market need, BexBack offers a powerful solution: 100x leverage on crypto futures trading, allowing traders to amplify their positions and maximize their profits from even the smallest market moves.

ROAD TOWN, British Virgin Islands, Aug. 02, 2025 (GLOBE NEWSWIRE) -- The recent Ethereum bull run has renewed momentum across the blockchain space, drawing increased attention to emerging platforms that combine utility with innovation. Among them, Ozak AI is gaining investor interest as it announces the launch of Stage 4 of its $OZ token presale, now priced at $0.005.

NexZen Extracts, a premium name in hemp-derived cannabinoid products, has been officially recognized as the Choice of THCA flower brand of 2025

DALLAS, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on August 1, 2025, the Compensation Committee of Taysha's Board of Directors granted one new employee an option to purchase 90,000 shares of the Company's common stock in connection with their employment. The stock option was granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individual entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4).